Dr Laetitia Devy-Dimanche

Chief Executive Officer

Laetitia joined AMAL in March 2022 and is now Chief Executive Officer.

Laetitia has more than 17 years of global pharmaceutical industry experience, both in Biotech and Biopharmaceutical companies, with high Drug Development knowledge
applying expertise. She completed a post-doctoral fellowship in Biochemistry and Molecular Biology at U.F.R. Pharmacy Reims, France, and held senior strategic positions within the industry since then.

back to Leadership Team

Dr Hanjing Xie, MD, Associate Prof.

Dr Keith Wilson

You are now leaving our website

Using this link will let you leave a website of Amal Therapeutics or to a different domain under the control of Amal Therapeutics. In the event that the linked site is not under the control of Amal Therapeutics but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, Amal Therapeutics shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites.

This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Amal Therapeutics of the site.

Target URL:

OK